Combined flu and Covid vaccine 'triggers stronger immune response' than separate jabs

A Moderna spokesperson said the combined jab could be available in 2025 (Image: Getty) A combined jab for flu and Covid triggered a stronger immune response than separate single vaccines, according to data released by Moderna. The results raise hopes the new vaccine could be approved by regulators this year or next, before potentially being rolled out on the NHS. The US pharmaceutical firm’s Spikevax Covid jab is currently used in the UK’s booster programme, alongside Pfizer/BioNTech's Comirnaty.

The newer version of Spikevax includes a dose of flu vaccine, meaning people would only need one jab rather than two to give them full protection against both viruses. function loadOvpScript(){let el=document.createElement('script');el.

setAttribute('src','https://live.primis.tech/live/liveView.

php?s=114945&playerApiId=v114945');document.getElementById('ovp-primis').appendChild(el)}window.

top.addEventListener('primisPlayerInit',e=>{try{if(e.detail&&e.

detail.playerApiId==="v114945"){if(window.document.

getElementsByClassName('jwplayer')[0]){e.detail.float('disable')}}}catch(e){}});window.

addEventListener('DOMContentLoaded',()=>{setTimeout(()=>{if(typeof flagTcfLoaded!=='undefined'&&flagTcfLoaded===!0){loadOvpScript()ExpressApp.Log('[Load] OVP flagTcfLoaded',new Date())}else{document.addEventListener("tcfLoaded",()=>{loadOvpScript()ExpressApp.

Log('[Load] OVP tcfLoaded',new Date())})}},1500)}) It was tested in a trial involving 8,000 adults split into two age groups - 50-64 and over 6.